Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,864.00
Bid: 2,863.00
Ask: 2,865.00
Change: 14.00 (0.49%)
Spread: 2.00 (0.07%)
Open: 2,841.00
High: 2,868.00
Low: 2,812.00
Prev. Close: 2,850.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FY2017 Q1 Performance update

27 Jul 2016 07:00

RNS Number : 3169F
3i Group PLC
27 July 2016
 

27 July 2016

 

3i Group plc

FY2017 Q1 performance update

 

A solid start to the year with good levels of investment and portfolio activity

 

· NAV per share of 538 pence and total return of 16.4% at 30 June 2016

 

· Private Equity generated cash proceeds of £438 million in the quarter and will generate a further c.£143 million from the sales of Geka, Polyconcept and UFO Moviez in Q2

 

· Announced c.£283 million Private Equity investment in two new companies, Schlemmer and BoConcept

 

· Supported 3i Infrastructure plc's ("3iN") successful capital raising, investing £131 million to maintain our 34% shareholding

 

· Our well funded balance sheet and our portfolio of international companies position us well for the current environment

 

· Ex-dividend NAV per share of 522 pence with the 16 pence final FY2016 dividend paid on 22 July 2016

 

 

 

Simon Borrows, Chief Executive, commented:

 

"This was a busy quarter for 3i. To date we have announced some £580 million of realisations, as well as two new investments in Private Equity and a £131 million further investment in 3iN. As we announced on 30 June 2016, we have materially increased the valuation of Action to £1.5 billion.

 

We remain focused on executing our strategy and we will continue to drive the performance of our portfolio and seek attractive investment opportunities."

 

 

Private Equity

Investments

The team started the year with a promising pipeline of opportunities. In May we announced a €181 million investment in Schlemmer, a global leader in cable management solutions for the automotive industry headquartered in Germany. The investment is subject to customary regulatory approvals. In early July we announced a c.£132 million investment in BoConcept, an urban interior design brand in the affordable luxury segment headquartered in Denmark.

 

 

Realisations

 

We generated total cash proceeds in the quarter of £438 million. The strong realisations activity has continued in the second quarter and we agreed the sales of GEKA, Polyconcept and UFO Moviez in July 2016.

 

 Realisation proceeds£m

Full realisations

Mayborn

136

Amor

88

Eltel

20

Partial realisations

Basic-Fit

82

Quintiles*

34

Scandlines

16

Other

9

Refinancings

ATESTEO

48

Deferred consideration

Other

5

Total Q1 2016 cash proceeds

438

Q2 full realisations to date

Geka

83

Polyconcept

44

UFO Moviez

16

Total Private Equity realisations

581

 

* As at 30 June 2016, 3i held a c.1% stake in Quintiles.

 

Portfolio performance

 

As announced previously, we have materially increased Action's valuation to £1,488 million1 (31 March 2016: £902 million). This implies a post discount run-rate EBITDA multiple of 18.2x applied to the run-rate earnings as at 31 March 20162 and is equivalent to a post-discount multiple of less than 15x the expected run rate earnings at 31 December 2016.

 

The Private Equity portfolio continued to perform well in the quarter despite the challenging macroeconomic and market conditions. Overall, our decision to adjust multiples to reflect sector and multiple trends helped to mitigate the immediate impact of the market volatility caused by the result of the EU referendum. Our exposure to the sectors which have experienced the most obvious challenges over the last 12 months remains limited and, while we cannot be immune to what we expect will be a volatile and challenging period, we expect the portfolio to be generally resilient as the wider implications of Brexit unfold. 

 

 

Infrastructure

 

As part of 3iN's successful £385 million capital raising, 3i invested £131 million to maintain its 34% shareholding.

 

 

Debt Management

 

The Debt Management team closed Harvest XV, a new European CLO, for €413 million in May 2016, raising new assets under management of £335 million. 3i invested £22 million into this CLO.

 

 

 

Top 10 investments by value at 30 June 2016

 

Valuation1

Valuation1

Valuation

Valuation

Mar-16

Jun-16

basis

currency

£m

£m

Activity in the quarter

Action

Earnings

EUR

902

1,488

Increase in valuation due to a number of third-party offers and continued strong financial and operational performance

3i Infrastructure plc

Quoted

GBP

464

617

Invested £131m to maintain our 34% interest

Scandlines

DCF

EUR

369

374

Weener Plastic

Earnings

EUR

173

183

Audley Travel

Earnings

GBP

158

163

Basic-Fit

Quoted

EUR

208

152

Listed on Amsterdam Stock Exchange and proceeds of £82m repaid shareholder loans

Q Holding

Earnings

USD

120

127

Christ

Earnings

EUR

117

114

AES Engineering

Earnings

GBP

92

100

ATESTEO

Earnings

EUR

130

96

Refinancing returned £48m of proceeds

 

The top 10 investments in this table comprise 68% (31 March 2016: 59%) of the total Proprietary Capital portfolio by value. This table does not include one investment that has been excluded for commercial reasons.

 

 

Total return and NAV position

 

We continue to generate good levels of cash income whilst remaining disciplined over costs and operating cash profit was £14 million in the quarter.

 

The increase in Action's valuation resulted in a corresponding uplift in the amounts of carry receivable and payable. The net carry payable recognised in the quarter was £53 million. We expect that net carry payable will be accrued at the lower end of 10-15% of gross investment return for this financial year.

 

The positive foreign exchange impact was 20 pence in the quarter as the portfolio benefitted from the weakening of sterling following the result of the UK's EU referendum. Based on the balance sheet at 30 June 2016, a 1% movement in the euro and US dollar would result in a total return movement of £30 million and £7 million respectively.

 

These factors, together with the value growth from our investment portfolio resulted in an increase in diluted NAV per share to 538 pence (31 March 2016: 463 pence) and 522 pence ex-dividend.

 

 

Balance sheet and dividend

 

The Group's balance sheet remains strong and well funded. Net cash increased to £437 million, principally due to good levels of realised proceeds in the quarter. The 16 pence final FY2016 dividend was paid on 22 July and amounts to £154 million.

 

 

Notes

 

1. Balance sheet values are stated net of foreign exchange translation. Where applicable, the GBP equivalents at 30 June 2016 in this update have been calculated at a currency exchange rate of €1.1973:£1 and $1.3298:£1 respectively. At 30 June 2016, 57% of the Group's net assets are in euro and 13% are in US dollar.

2. Action is valued using a multiple of its run-rate earnings for the 12 months to the quarter end preceding the reporting period. The valuation uplift to £1,488 million at 30 June 2016 is calculated using run-rate earnings to 31 March 2016.

 

 

For further information, please contact:

Silvia SantoroInvestor Relations DirectorTel: 020 7975 3258

Toby Bates

Interim Communications DirectorTel: 020 7975 3032

 

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

All statements in this performance update relate to the three month period ended 30 June 2016 unless otherwise stated. The financial information is unaudited and is presented on 3i's non-GAAP Investment basis in order to provide users with the most appropriate description of the drivers of 3i's performance. Net asset value ("NAV") and total return are the same on the Investment basis and on an IFRS basis. Details of the differences between 3i's consolidated financial statements prepared on an IFRS basis and under the Investment basis are provided in the 2016 Annual report and accounts. There have been no material changes to the financial position of 3i from the end of this quarter to the date of this announcement.

 

- Ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRFMRTMBMTBIF
Date   Source Headline
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review
8th Jun 20232:51 pmRNSDirector/PDMR Shareholding
7th Jun 202311:21 amRNSDTR 6.3.5
5th Jun 20233:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.